Irvine, CA—June 25, 2019—Modulim, recognized leader in optical imaging solutions for the non-invasive assessment of tissue health, is pleased to announce that it has appointed six inaugural members to its newly-formed Medical Advisory Board.
The board members include top practicing and community-based clinicians who have a wide range of skills and expertise in areas such as practice management, reimbursement and patient care and are committed to facilitating advancements in the treatment of foot complications, including ulcers, nonhealing wounds, infections and amputations.
“Modulim’s Medical Advisory Board consists of leading foot and ankle specialists. We’re excited to partner with them to further advance our clinical and scientific knowledge and benefit from their guidance and support to educate clinicians on the clinical benefits of Clarifi to their patients and practice,” said Gary Marston, Vice President of Sales & Marketing at Modulim.
The company’s proprietary spatial frequency domain imaging (SFDI) based technology solution – the ClarifiTM Imaging System – may be used by clinicians to help them identify compromised circulation that can’t be detected by physical assessment.
“One common goal that we share with each of these medical leaders is prevention; Clarifi can provide healthcare providers with clinically actionable information that can help them identify patients with potential compromised circulation and pinpoint areas of concern, for timely, targeted care,” said David Cuccia, Ph.D., Modulim’s founding CEO and CTO.
Inaugural members of the Medical Advisory Board include:
Jeffrey D. Lehrman, DPM, FASPS, MAPWCA, CPC, was named as the Inaugural Chair of Modulim’s Medical Advisory Board. Dr. Lehrman is in private practice at A Step Ahead Foot & Ankle Center in Fort Collins, Colorado, and the owner of Lehrman Consulting, LLC. Follow him on Twitter.
Matthew G. Garoufalis, DPM, FASPS, FACFAOM, CWS, FFPM, RCPS (Glasg), is in private practice at Professional Foot Care Specialists, PC, and is the Immediate Past President of the International Federation of Podiatrists and Past President of the American Podiatric Medical Association (APMA).
Michael J. King, DPM, FACFAS, FASPS, has been in private practice for 32 years in New England and is Board Certified by the American Board of Foot and Ankle Surgery; he currently serves as the Medical Director of Upperline Healthcare, Inc., in Nashville, Tennessee, and is the Past President of both the APMA and the Massachusetts Podiatric Medical Society.
Kevin C. McDonald, DPM, is the President of InStride Foot and Ankle Specialists and editor of, “The Diabetic Foot Book.” Dr. McDonald is also a Member of the APMA and Past President and Member of the North Carolina Foot and Ankle Society. For more information, visit his website at InStride Family Foot Care.
Jennifer Spector, DPM, FACFAS, is a Podiatric Surgeon, President and Executive Board of the American Association for Women Podiatrists (AAWP), and former AAWP Scientific Conference Chair.
Phillip E. Ward, DPM, provides podiatric services at Cape Fear Valley Foot and Ankle Center in North Carolina and is certified by the American Board of Foot and Ankle Surgery and American Board of Podiatric Medicine. Dr. Ward is Past President of the APMA, a Member of the American Medical Association’s Editorial Board and a Current Procedural Terminology Assistant and APMA Advisor to The American Medical Association (Current Procedural Terminology Panel).
Modulim’s Medical Advisory Board will meet regularly to provide input on clinical research, best practices, product design, and clinical education. The Medical Advisory Board will serve as a strategic resource as the company establishes partnerships with leading clinical centers of excellence.
“We’re proud to be working alongside some of the most widely recognized clinical specialists and welcome them to our Medical Advisory Board,” added Dr. Cuccia.
Modulim is a pioneer in subsurface optical imaging powered by SFDI, an advanced imaging technique co-invented by founding CEO and CTO David Cuccia, Ph.D. SFDI is a non-invasive tissue oxygen saturation technology that combines structured illumination with multiple wavelengths of light (visible and near-infrared) to allow for deeper and layer-specific assessment of tissue oxygenation and hemoglobin. This unique technology deciphers the reflection, absorbance, and scattering of light in tissue to accurately measure key biomarkers of tissue health and quantifies two key perfusion metrics not identified by any other technology: HbT1 and HbT2. The new Clarifi™ Imaging System, powered by SFDI, is indicated for measuring tissue oxygenation in patients with potential circulatory compromise. For more information, visit modulim.com
VP Sales and Marketing